UPMC Health Plan (UPMC) recently announced it has joined in a value-based contract with pharmaceutical company Alkermes for Vivitrol, an injected drug that helps to block opioid cravings. The contract was led by the Center for Value-Based Pharmacy Initiatives, a non-profit group that is part of UPMC’s Insurance Services Division.
With a value-based contract—according to statements from UPMC leadership—the focus shifts from paying for a drug to paying for results, overall benefiting the consumer’s health. The contract will accomplish this by linking reimbursement for Vivitrol with positive clinical outcomes among UPMC Health Plan members. UPMC also cited the contract as timely, as the opioid crisis continues to take the lives of thousands across the country.
UPMC (University of Pittsburgh Medical Center) Health Plan, Inc. operates as an insurance company. The company provides life, health, and disability insurance services to consumers in the United States. The UPMC Insurance Services Division offers a full range of group health insurance, Medicare, special needs, CHIP, medical assistance, behavioral health, employee assistance, and workers’ compensation products and services to more than 3.4 million consumers.
This was reported by Cision PR Newswire on August 30, 2018.
Contact Information: UPMC Health Plan, Inc., 600 Grant Street, Pittsburgh, Pennsylvania 15219; (877) 563-0292; Website: www.upmchealthplan.com